Early high-dose continuous veno-venous hemofiltration alleviates the alterations of CD4+ T lymphocyte subsets in septic patients combined with acute kidney injury.
Jin B, Cao D, Yang N, Wang L, Li R, Liu X, Gong P.
Artif Organs. 2022 Jul;46(7):1415-1424. doi: 10.1111/aor.14199. Epub 2022 Feb 17.
PMID:35132659
Combined Hemoperfusion and Continuous Veno-Venous Hemofiltration for Carbamazepine Intoxication.
Baylis S, Costa-Pinto R, Hodgson S, Bellomo R, Baldwin I.
Blood Purif. 2022;51(9):721-725. doi: 10.1159/000520520. Epub 2021 Dec 8.
PMID:34879379
Continuous renal replacement therapy and extended indications.
Ronco C, Reis T.
Semin Dial. 2021 Nov;34(6):550-560. doi: 10.1111/sdi.12963. Epub 2021 Mar 12.
PMID:33711166
CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study.
Jonckheer J, Spapen H, Debain A, Demol J, Diltoer M, Costa O, Lanckmans K, Oshima T, Honoré PM, Malbrain M, De Waele E.
BMC Nephrol. 2019 Jun 17;20(1):222. doi: 10.1186/s12882-019-1378-y.
PMID:31208356
Prognostic risk factors in patients with refractory heart failure treated with continuous veno-venous hemofiltration.
Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P.
Crit Care. 2023 Jun 7;27(1):222. doi: 10.1186/s13054-023-04519-1.